Anticoagulants
- You have accessRestricted accessLetter by Mojadidi et al Regarding Article, “Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis”Mohammad K. Mojadidi, Muhammad O. Zaman and Nimesh K. PatelStroke. 2018;49:e212, originally published April 11, 2018https://doi.org/10.1161/STROKEAHA.118.021403
- You have accessRestricted accessLetter by Guijarro Regarding Article, “Cerebrovascular Outcomes With Proton Pump Inhibitors and Thienopyridines: A Systematic Review and Meta-Analysis”Carlos GuijarroStroke. 2018;49:e169, originally published March 16, 2018https://doi.org/10.1161/STROKEAHA.118.020990
- You have accessRestricted accessAntiplatelet and Anticoagulant Agents for Secondary Prevention of Thromboembolic Events in People With Antiphospholipid SyndromeMalgorzata M. Bala, Magdalena Celinska-Lowenhoff, Wojciech Szot, Agnieszka Padjas, Mateusz Kaczmarczyk, Mateusz J. Swierz and Anetta UndasStroke. 2018;49:e41-e42, originally published February 6, 2018https://doi.org/10.1161/STROKEAHA.117.019900
- You have accessRestricted accessReal-World Use of Apixaban for Stroke Prevention in Atrial FibrillationA Systematic Review and Meta-AnalysisMarco Proietti, Imma Romanazzi, Giulio Francesco Romiti, Alessio Farcomeni and Gregory Y.H. LipStroke. 2018;49:98-106, originally published November 22, 2017https://doi.org/10.1161/STROKEAHA.117.018395
- You have accessRestricted accessShould Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds Be Anticoagulated?Ashkan Shoamanesh, Andreas Charidimou, Mukul Sharma and Robert G. HartStroke. 2017;48:3408-3412, originally published November 7, 2017https://doi.org/10.1161/STROKEAHA.117.018467
- You have accessRestricted accessHemorrhagic Transformation After Large Cerebral Infarction in Rats Pretreated With Dabigatran or WarfarinIl Kwon, Sunho An, Jayoung Kim, Seung-Hee Yang, Joonsang Yoo, Jang-Hyun Baek, Hyo Suk Nam, Young Dae Kim, Hye Sun Lee, Hyun-Jung Choi and Ji Hoe HeoStroke. 2017;48:2865-2871, originally published September 13, 2017https://doi.org/10.1161/STROKEAHA.117.017751
- You have accessRestricted accessResponse by Barreto and Grotta to Letter Regarding Article, “Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)”Andrew D. Barreto and James C. GrottaStroke. 2017;48:e259, originally published July 28, 2017https://doi.org/10.1161/STROKEAHA.117.018294
- You have accessRestricted accessEmergency Coagulation Assessment During Treatment With Direct Oral AnticoagulantsLimitations and SolutionsMatthias Ebner, Ingvild Birschmann, Andreas Peter, Florian Härtig, Charlotte Spencer, Joachim Kuhn, Gunnar Blumenstock, Christine S. Zuern, Ulf Ziemann and Sven PoliStroke. 2017;48:2457-2463, originally published August 3, 2017https://doi.org/10.1161/STROKEAHA.117.017981
- You have accessRestricted accessGeographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial FibrillationInmaculada Hernandez, Samir Saba and Yuting ZhangStroke. 2017;48:2289-2291, originally published June 27, 2017https://doi.org/10.1161/STROKEAHA.117.017683
- You have accessRestricted accessTo Treat or Not to TreatAnticoagulants as Secondary Preventives to the Oldest Old With Atrial FibrillationPeter Appelros, Bahman Farahmand, Andreas Terént and Signild ÅsbergStroke. 2017;48:1617-1623, originally published May 9, 2017https://doi.org/10.1161/STROKEAHA.117.016902
Pages
Current Issue
Stroke
May 2018, Volume 49, Issue 5
Search This Journal
Related Collections
- Anticoagulants (536)
- Cardiovascular Surgery (103)
- Compliance/Adherence (47)
- Nursing (22)
- Pacemaker (7)
- Pharmacology (105)
- Rehabilitation (633)
- Revascularization (168)
- Stent (47)
- Transplantation (14)
- Treatment (4110)